Massachusetts Financial Services’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$578K Sell
45,051
-2,039
-4% -$16.6K ﹤0.01% 926
2026
Q2
$467K Sell
47,090
-1,877
-4% -$15.7K ﹤0.01% 954
2026
Q1
$300K Sell
48,967
-1,306
-3% -$10.9K ﹤0.01% 921
2025
Q4
$418K Buy
50,273
+20,005
+66% +$215K ﹤0.01% 882
2025
Q3
$441K Buy
+30,268
New +$362K ﹤0.01% 835

Other funds holding DNA

Massachusetts Financial Services's DNA Position: Q3 2026 in Review

Massachusetts Financial Services reduced its Ginkgo Bioworks (DNA) stake by 4.3% in Q3 2026, selling an estimated $16.6K and leaving 45,051 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #926.

Massachusetts Financial Services first reported a position in DNA in Q3 2025 and has held it in 5 quarters since. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Massachusetts Financial Services held 45,051 shares of Ginkgo Bioworks worth $578K as of Q3 2026.
  • Massachusetts Financial Services sold 2,039 Ginkgo Bioworks shares in Q3 2026, an estimated $16.6K.
  • Ginkgo Bioworks made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q3 2026, its #926 holding.
  • Massachusetts Financial Services first reported a position in Ginkgo Bioworks in Q3 2025 and has held it in 5 quarters since.
  • 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.